Management of CMV Disease in HIV Infection

Gallant J.E. , Moore R.D. , Richman D.D. , Keruly J. , Chaisson R.E. . Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group. J Infect Dis 1992; 166: 1223–7.

Pertel P. , Hirshtick R. , Phair J. . Risk of developing cytomegalovirus retinitis in persons infected with the human immunodeficiency virus. J Acquir Immune Defic Syndr 1992; 15: 1069–74.

Palella F.J. , Delaney K.M. , Moorman A.C. . Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998; 338: 853.

Kuppermann B.D. , Petty J.G. , Richman D.D. . Correlation between CD4 counts and prevalence of cytomegalovirus retinitis and human immunodeficiency virus related non-infectious retinal vasculopathy in patients with acquired immunodeficiency syndrome. Am J Ophthalmol 1993; 115: 575–82.

Baldassano V. , Dunn J.P. , Feinberg J. , Jabs D.A. . Cytomegalovirus retinitis and low CD4 T-lymphocyte counts. N Engl J Med 1995; 333: 670.

Whitley R.J. , Jacobson M.A. , Friedberg D.N. . Guidelines for the treatment of cytomegalovirus diseases in patients with AIDS in the era of potent antiretroviral therapy. Arch Intern Med 1998; 158: 197–969

Studies of ocular complications of AIDS research group in collaboration with AIDS Clinical Trials Group. Mortality in patients acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis. N Engl J Med 1992; 326: 213–20.

Studies of ocular complications of AIDS research group in collaboration with AIDS clinical trials group. Antiviral effects of foscarnet and ganciclovir therapy on human immunodeficiency virus p24 antigen in patients with AIDS and cytomegalovirus. J Infect Dis 1995; 172: 613–21.

Lalezari J.P. , Stagg R.J. , Kuppermann B.D. . Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS. Ann Intern Med 1997; 126: 257–63.

Studies of ocular complications of AIDS Research Group, AIDS Clinical Trials Group. Parenteral cidofovir for cytomegalovirus retinitis in patients with AIDS: the HPMPC peripheral cytomegalovirus retinitis trial: a randomised, controlled trial. Ann Intern Med 1997; 126: 264–74.

Musch D.C. , Martin D.F. , Gordon J.F. . Treatment of cytomegalovirus retinitis with a sustained-release ganciclovir implant. The Ganciclovir Implant Study Group. N Engl J Med 1997; 337: 83–90.

Martin D.F. , Parks D.J. , Mellow D.S. . Treatment of cytomegalovirus retinitis with an intraocular sustained-release ganciclovir implant; a randomised controlled clinical trial. Arch Ophthalmol 1994; 112: 1531–9.

Martin D. , Kuppermann B.D. , Wolitz R. , Palestine C. , Robinson G. . Combined oral ganciclovir (GCV) an intravitreal GCV implant for treatment of patients with cytomegalovirus (CMV) retinitis: a randomised controlled study. 37th ICAAC. 28 September-1 October 1997, Toronto (Abstract LB-9)

Drew W.L. , Ives D. , Lalezari J.P. . Oral ganciclovir as maintenance treatment for cytomegalovirus retinitis in patients with AIDS. N Engl Med 1995; 333: 615–20.

Oral Ganciclovir European and Australian Cooperative Study Group. Intravenous versus oral ganciclovir European/Australian cooperative study of efficacy and safety in the prevention of cytomegalovirus retinitis recurrence in patients with AIDS. AIDS 1995; 9: 471–7.

Torriani F.J. , Macdonald J.C. , Karevellas M. , Freeman W.N. . Lack of progression after discontinuation of maintenance therapy for cytomegalovirus retinitis in AIDS patients responding to highly active antiretroviral therapy. 37th ICAAC. 28 September-1 October 1997, Toronto (Abstract I-33)

Komanduri K.V. , Viswanathan M.N. , Wender Z.D. . Restoration of cytomegalovirus specific CD4 T lymphocyte responses after ganciclovir and highly active antiretroviral therapy in individuals infected with HIV. Nature Med 1998; 4: 953–6.

Jabs D.A. , Enger C. , Dunn J.P. , Forman M. . Cytomegalovirus retinitis and viral resistance: ganciclovir resistance. CMV retinitis and viral resistance study group. J Infect Dis 1998; 177: 770–3.

Jabs D.A. , Enger C. , Foreman M. , Dunn J.P. . Incidence of foscarnet resistance and cidofovir resistance in patients treated for cytomegalovirus retinitis. The CMV resistance and viral resistance study group. Antimicrob Agents Chemo 1998; 42: 2240–4.

Gilbert C. , Hatfield J. , Toma E. , Lalonde R. , Bergeron M.G. , Bovin G. . Emergence and prevalence of cytomegalovirus UL97 mutations associated with ganciclovir resistance in AIDS patients. AIDS 1998; 12: 125–9.

Studies of ocular complications of AIDS research group in collaboration with AIDS clinical trials group. Combination of foscarnet and ganciclovir therapy vs monotherapy for the treatment of relapsed cytomegalovirus retinitis in patients with AIDS. Arch Ophthalmol 1996; 114: 23–32.

Lalezari J.P. , Kemper C. , Stagg R. . A randomised, controlled study of the safety and efficacy of intravenous cidofovir for the treatment of relapsing cytomegalovirus retinitis in patients with AIDS. J Acquir Immune Defic Syndr 1998; 17: 339–44.

Dieterich D.T. , Kotler D.P. , Busch D.F. . Ganciclovir treatment of cytomegalovirus colitis in AIDS: a randomised double blind placebo-controlled multicentre study. J Infect Dis 1993; 167: 278–82.

Blanshard C. , Benhamon Y. , Dohin E. , Lernestedt J.D. , Gazzard B.G. , Katlama C. . Treatment of AIDS-associated gastrointestinal cytomegalovirus infection with foscarnet and ganciclovir: a randomised comparison. J Infect Dis 1995; 172: 622–8.

Gozlan J. , El Amrani M. , Baudrimoud M. . A prospective evaluation of clinical criteria and polymerase chain reaction assay of cerebrospinal fluid for the diagnosis of CMV related neurological disease during AIDS. AIDS 1995; 9: 253–60.

Cohen B.A. , McCarthur J.C. , Grohman S. . Neurological prognosis of cytomegalovirus polyradiculopathy in AIDS. Neurology 1993; 43: 493–9.

Spector S.A. , Wong R. , Hsia K. , Pilcher M. , Stempien M.J. . Plasma cytomegalovirus (CMV) DNA load predicts CMV disease and survival in AIDS patients. J Clin Invest 1998; 101: 497–502.

Bowen E.F. , Sabine C.A. , Wilson P. . Cytomegalovirus (CMV) viraemia detected by polymerase chain reaction identifies a group of HIV positive patients at high risk of CMV disease. AIDS 1997; 11: 889–93.

Spector S.A. , McKinley G.P. , Lalezari J.P. . Oral ganciclovir for the prevention of cytomegalovirus disease in persons with AIDS. N Engl J Med 1996; 334: 1491–7.